Funding for this research was provided by:
Roche Molecular Systems
Received: 7 June 2018
Accepted: 19 February 2019
First Online: 26 February 2019
Ethics approval and consent to participate
: This study utilized deidentified claims data from inpatient and outpatient visits as well as pharmacies. All database records are deidentified in full compliance with US patient confidentiality requirements set forth in the Health Insurance Portability and Accountability Act. Because this study used only deidentified patient records and did not involve the collection, use, or transmittal of individually identifiable data, institutional review board approval to conduct this study was not necessary.
: Not applicable.
: RL was an employee of Roche during the time of this study and manuscript preparation. JS and FV are employees of Roche. YCL is employed by Genentech, a member of the Roche Group. BF and MT have received consulting fees from Roche. Roche Molecular System’s product portfolio includes the cobas Liat Strep A test (a CLIA Waived POC PCR test).
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.